Facts of Pomalyst (Pomalidomide) Capsules ?
- Medicine Name: Pomalyst
- Generic Name: Pomalidomide
- Approval Date: February 8, 2013
- Company Name: Celgene Corporation
- Available as (Form & Strength): Capsules: 1 mg, 2 mg, 3 mg, and 4 mg
POMALYST is a thalidomide analogue indicated, in combination with dexamethasone, for patients with multiple myeloma who have received at least two prior therapies including le nalidomide and a proteasome inhibitor and have demonstrated disease pr ogression on or within 60 days of completion of the last therapy
Store at 20°C-25°C (68°F-77°F); excursions permitted to 15°C-30°C (59°F-86°F).